Horizontal evaluation of the Canadian Drugs and Substances Strategy : evaluation report / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada.: HP5-177/2023E-PDF
"Canada is experiencing an unprecedented rate of substance use-related deaths and harms due to a number of complex, interrelated factors. The Canadian Drugs and Substances Strategy (CDSS), which was first announced in 2016, sets out the federal government's comprehensive, collaborative, compassionate, and evidence-based approach to drug policy that focuses on substance use as a public health issue. The CDSS replaced the National Anti-Drug Strategy (NADS), which was established in 2006, and the lead changed from the Department of Justice to Health Canada. From 2017 to 2022, Health Canada coordinated federal investments and activities across the full spectrum of legal and illegal substances under four pillars: prevention, treatment, harm reduction, and enforcement. ... This evaluation looked at all funded partners' activities from 2017-18 to 2021-22 under both horizontal initiatives and focused on progress made toward delivering on Pillar objectives and shared outcomes, including HC's Substance Use and Addictions Program (SUAP) and PHAC's Harm Reduction Fund activities to address Financial Administration Act requirements. However, activities related to tobacco and cannabis, including SUAP projects for these substances, were excluded from this evaluation as there were separate evaluations assessing activities related to these two substances"--Executive summary, page 5.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.931658&sl=0
| Department/Agency | Canada. Health Canada. Office of Audit and Evaluation, issuing body. Public Health Agency of Canada. Office of Audit and Evaluation, issuing body. |
|---|---|
| Title | Horizontal evaluation of the Canadian Drugs and Substances Strategy : evaluation report / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Évaluation horizontale de la Stratégie canadienne sur les drogues et autres substances : rapport d'évaluation. "Pub.: 230565"--Verso of cover. Includes bibliographical references (pages 77-87). |
| Publishing information | Ottawa, ON : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, August 2023. |
| Description | 1 online resource (87 pages) : colour illustrations |
| ISBN | 9780660693842 |
| Catalogue number |
|
| Departmental catalogue number | 230559 |
| Subject terms | Drug abuse -- Government policy -- Canada -- Evaluation. Substance abuse -- Government policy -- Canada -- Evaluation. Drug abuse -- Canada -- Prevention -- Evaluation. Substance abuse -- Canada -- Prevention -- Evaluation. Drug abuse -- Treatment -- Canada -- Evaluation. Substance abuse -- Treatment -- Canada -- Evaluation. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: